基于术前数据的机器学习预测慢性鼻窦炎手术结局
本研究用242例初次接受内镜鼻窦手术的慢性鼻窦炎患者术前数据训练机器学习模型,预测术后SNOT-22总分是否达到最小临床重要差异。Ensemble模型区分度最高(AUC 0.89,95%CI 0.87-0.91),准确率87.8%,与逻辑回归特异性相同,可用于「纳入」可能获益的患者。
要点
- Ensemble模型预测ESS后MCID的AUC为0.89,准确率87.8%。
- XGBoost敏感性最高(97.1%)但特异性仅46.7%。
- 年龄、术前SNOT-22、PHQ-2、鼻塞和面部疼痛/压迫感最具预测力。
核心结论
- Ensemble机器学习模型在预测慢性鼻窦炎患者内镜鼻窦手术后达到最小临床重要差异方面,获得最高的总体准确率和区分度,特异性与逻辑回归并列最高。
- 该模型可用于临床决策中「纳入」可能从手术获益的患者,但需多中心队列验证。
研究设计与样本
- 研究纳入242例接受初次内镜鼻窦手术的慢性鼻窦炎患者,用术前数据训练和测试机器学习模型。
主要发现
- Ensemble模型区分度最高:AUC 0.89(95%CI 0.87-0.91),逻辑回归AUC 0.85(95%CI 0.83-0.87),XGBoost AUC 0.74(95%CI 0.72-0.76),p<0.05。
- Ensemble准确率87.8%,逻辑回归和XGBoost均为81.6%。
- XGBoost敏感性最高(97.1%),逻辑回归76.5%,Ensemble 85.3%;XGBoost特异性较差(46.7%),逻辑回归和Ensemble均为93.3%。
- Ensemble模型中最具预测力的因素为年龄、术前SNOT-22评分、PHQ-2评分、鼻塞和面部疼痛/压迫感。
关键数值与推荐
- 预测目标为术前与术后SNOT-22总分差值达到最小临床重要差异(MCID)。
- Ensemble模型AUC 0.89(95%CI 0.87-0.91),准确率87.8%,特异性93.3%。
- 逻辑回归AUC 0.85(95%CI 0.83-0.87),准确率81.6%,敏感性76.5%,特异性93.3%。
- XGBoost AUC 0.74(95%CI 0.72-0.76),准确率81.6%,敏感性97.1%,特异性46.7%。
临床怎么用
- 术前可利用Ensemble模型预测患者术后SNOT-22是否达到MCID,辅助「纳入」可能获益于ESS的患者。
- 模型尚需多中心队列验证后方可作为临床决策的辅助工具。
局限性
- 模型仅在单中心242例患者中训练和测试,需多中心队列验证。
- 原文未报告外部验证结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Endoscopic sinus surgery (ESS) fails to adequately address symptoms in some chronic rhinosinusitis (CRS) patients. This study aims to evaluate machine learning models (MLMs) in predicting ESS outcomes from preoperative data. METHODS: CRS patients who underwent primary ESS were used to train and test MLMs for the identification of the minimal clinically important difference (MCID) between pre- and post-operative total SNOT-22 scores. Fifty-nine preoperative predictors were included in the MLMs. Each model was optimized using K-fold cross validation. The performance of two MLMs and a conventional logistic regression (LR) model was evaluated. RESULTS: The study cohort constituted 242 patients. The Ensemble model achieved the highest discriminative performance (Ensemble area-under-the-curve [AUC] 0.89, 95% CI 0.87-0.91; LR AUC 0.85, 95% CI 0.83-0.87; XGBoost AUC 0.74, 95% CI 0.72-0.76, p < 0.05) and accuracy (Ensemble 87.8%; LR 81.6%; XGBoost 81.6%). The XGBoost model achieved the highest sensitivity (XGBoost 97.1%; LR 76.5%; Ensemble 85.3%) but poorer specificity (XGBoost 46.7%; LR 93.3%; Ensemble 93.3%). The most predictive factors in the Ensemble model were age, preoperative SNOT-22 and Patient Health Questionnaire 2 (PHQ-2) scores, nasal obstruction, and facial pain/pressure. CONCLUSION: The Ensemble MLM achieved the highest overall accuracy and discriminative performance and matched LR for the highest specificity, suggesting that this model could be used in clinical decision-making to "rule in" patients likely to achieve MCID after ESS. This is the highest performance achieved in an MLM trained toward clinical outcomes in CRS. After validation in a multicenter cohort, the Ensemble MLM could become a useful adjunct in clinical decision-making for ESS.
引用
- Raghavan A, Sage E, Al-Ghezi M, et al. Predicting Surgical Outcomes in Chronic Rhinosinusitis From Preoperative Patient Data: A Machine Learning Approach. Int Forum Allergy Rhinol. 2025. PMID: 41263474. doi:10.1002/alr.70068
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。